These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6093068)

  • 1. Pertussis encephalopathy with a normal brain biopsy and elevated lymphocytosis-promoting factor antibodies.
    Davis LE; Burstyn DG; Manclark CR
    Pediatr Infect Dis; 1984; 3(5):448-51. PubMed ID: 6093068
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenetic significance of Bordetella pertussis toxin].
    Finger H
    Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
    [No Abstract]   [Full Text] [Related]  

  • 3. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
    Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
    Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis encephalopathy in an adult: case report and review.
    Halperin SA; Marrie TJ
    Rev Infect Dis; 1991; 13(6):1043-7. PubMed ID: 1775835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis.
    Pittman M
    Rev Infect Dis; 1979; 1(3):401-12. PubMed ID: 233166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to Bordetella pertussis in human colostrum and their protective activity against aerosol infection of mice.
    Oda M; Cowell JL; Burstyn DG; Thaib S; Manclark CR
    Infect Immun; 1985 Feb; 47(2):441-5. PubMed ID: 2857154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concept of pertussis as a toxin-mediated disease.
    Pittman M
    Pediatr Infect Dis; 1984; 3(5):467-86. PubMed ID: 6093069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Class-specific antibody response to lymphocytosis promoting factor (LPF) and fimbriae (F) in pertussis.
    Viljanen MK; Mertsola J; Kuronen T; Ruuskanen O
    Dev Biol Stand; 1985; 61():337-40. PubMed ID: 2872122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutralizing antibodies to pertussis toxin in whooping cough.
    Granström M; Granström G; Gillenius P; Askelöf P
    J Infect Dis; 1985 Apr; 151(4):646-9. PubMed ID: 2857752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody response to pertussis toxin in patients with clinical pertussis measured by enzyme-linked immunosorbent assay.
    Zackrisson G; Krantz I; Lagergård T; Larsson P; Sekura R; Sigurs N; Taranger J; Trollfors B
    Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):149-54. PubMed ID: 2899027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population.
    Lau RC
    N Z Med J; 1989 Oct; 102(878):560-2. PubMed ID: 2554227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative toxicity, protective, histamine sensitizing and leucocytosis promoting activities in mice of Bordetella pertussis culture fluid, bacterial cells and cell extracts.
    Megret F; Fournier JM; Alouf JE
    Med Microbiol Immunol; 1984; 173(4):225-32. PubMed ID: 6096686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.
    Watanabe M
    Microbiol Immunol; 1984; 28(5):509-15. PubMed ID: 6088952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis.
    Frühwirth M; Wolf H; Heininger H; Guggenbichler JP; Stehr E
    Adv Exp Med Biol; 1995; 371B():777-83. PubMed ID: 7502896
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of neutralising human recombinant antibodies to pertussis toxin.
    Williamson P; Matthews R
    FEMS Immunol Med Microbiol; 1999 Apr; 23(4):313-9. PubMed ID: 10225291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pertussis encephalopathy with high cerebrospinal fluid antibody titers to pertussis toxin and filamentous hemagglutinin.
    Grant CC; McKay EJ; Simpson A; Buckley D
    Pediatrics; 1998 Oct; 102(4 Pt 1):986-90. PubMed ID: 9755273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections.
    Sato H; Ito A; Chiba J; Sato Y
    Infect Immun; 1984 Nov; 46(2):422-8. PubMed ID: 6094351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough.
    Winsnes R; Lønnes T; Møgster B; Berdal BP
    Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of antibodies against fimbria type 3 (Fim3) is useful diagnostic assay for pertussis.
    Oguchi K; Miyata A; Kazuyama Y; Noda A; Suzuki E; Watanabe M; Nakayama T
    J Infect Chemother; 2015 Sep; 21(9):639-46. PubMed ID: 26134278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crucial role of antibodies to pertactin in Bordetella pertussis immunity.
    Hellwig SM; Rodriguez ME; Berbers GA; van de Winkel JG; Mooi FR
    J Infect Dis; 2003 Sep; 188(5):738-42. PubMed ID: 12934190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.